文献速递乳腺MR

超快速乳腺MRI协议在鉴别乳腺良恶性病变中的有效性

The effectiveness of an ultrafast breast MRI protocol in the differentiation of benign and malignant breast lesions.
PubMed 文献 · Clin Radiol · 2023-03-23

本研究纳入54例BI-RADS 4或5类乳腺病变患者,在标准乳腺MRI中加入超快速序列,由3名放射科医生共识解读。结果显示恶性病变的最大斜率(MS)显著高于良性病变(13.27%/s vs 5.45%/s,p<0.0001),MS的AUC为0.836,表明超快速协议利用MS参数在鉴别乳腺良恶性病变方面具有高准确度的潜力。

要点

  • 超快速MRI的最大斜率(MS)可有效鉴别乳腺良恶性病变,AUC达0.836。
  • 恶性病变MS显著高于良性病变(13.27%/s vs 5.45%/s,p<0.0001)。
  • TTE和AVI在良恶性病变间无显著差异,鉴别价值有限。

关键影像表现/征象

  • 所有恶性病变和38.2%的良性病变在超快速协议上可见。
  • 恶性病变的最大斜率(MS)为13.27%/s,良性病变为5.45%/s,差异显著(p<0.0001)。
  • 时间强化(TTE)和动静脉指数(AVI)在良恶性病变间无显著差异。
  • 高级别导管原位癌(DCIS)的MS与浸润性导管癌(IDC)相似,低级别DCIS的MS较低(5.3%/s vs 14.8%/s),但差异无统计学意义。

诊断标准与关键数值

  • 最大斜率(MS)鉴别良恶性病变的AUC为0.836。
  • TTE的AUC为0.647,AVI的AUC为0.684。

临床应用与阅片要点

  • 阅片时可关注超快速序列上的最大斜率(MS),恶性病变通常表现为较高的MS值。
  • 注意TTE和AVI在良恶性鉴别中价值有限,不应单独依赖。
  • 低级别DCIS可能表现为较低的MS,需结合常规序列避免漏诊。

局限性

  • 单中心研究,样本量较小(54例患者,83个病灶)。
  • 仅38.2%的良性病变在超快速协议上可见,可能影响参数测量。
  • 低级别与高级别DCIS的MS差异未达统计学显著性,需更大样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To evaluate the effectiveness of an ultrafast breast magnetic resonance imaging (MRI) protocol in differentiating benign and malignant breast lesions.

MATERIALS AND METHODS: Fifty-four patients with Breast Imaging Reporting and Data System (BI-RADS) 4 or 5 lesions were recruited between July 2020 to May 2021. A standard breast MRI was performed with the inclusion of the ultrafast protocol between the unenhanced sequence and the first contrast-enhanced sequence. Three radiologists performed image interpretation in consensus. Ultrafast kinetic parameters analysed included the maximum slope (MS), time to enhancement (TTE), and arteriovenous index (AVI). These parameters were compared using receiver operating characteristics with p-values of <0.05 considered to indicate statistical significance.

RESULTS: Eighty-three histopathological proven lesions from 54 patients (mean age 53.87 years, SD 12.34, range 26-78 years) were analysed. Forty-one per cent (n=34) were benign and 59% (n=49) were malignant. All malignant and 38.2% (n=13) benign lesions were visualised on the ultrafast protocol. Of the malignant lesions, 77.6% (n=53) were invasive ductal carcinoma (IDC) and 18.4% (n=9) were ductal carcinoma in situ (DCIS). The MS for malignant lesions (13.27%/s) were significantly larger than for benign (5.45%/s; p<0.0001). No significant differences were seen for TTE and AVI. The area under the ROC curve (AUC) for the MS, TTE, and AVI were 0.836, 0.647, and 0.684, respectively. Different types of invasive carcinoma had similar MS and TTE. The MS of high-grade DCIS was also similar to that of IDC. Lower MS values were observed for low-grade (5.3%/s) compared to high-grade DCIS (14.8%/s) but the results were not significant statistically.

CONCLUSION: The ultrafast protocol showed potential to discriminate between malignant and benign breast lesions with high accuracy using MS.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Ramli Hamid, Ab Mumin, Wong, et al. The effectiveness of an ultrafast breast MRI protocol in the differentiation of benign and malignant breast lesions. Clin Radiol. 2023. PMID: 37029001. doi:10.1016/j.crad.2023.03.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。